New concepts in bilirubin and jaundice: Report of the third international bilirubin workshop, April 6-8, 1995, Trieste, Italy

Hepatology

Volumn 24, Issue 5, 1996, Pages 1296-1311

  Tiribelli, Claudio ^a   Ostrow, Donald ^b,c  

^a UNIVERSITY OF TRIESTE   (Italy)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANION TRANSPORT; ARTICLE; BILIRUBIN METABOLISM; CELL ORGANELLE; ENDOPLASMIC RETICULUM; HEMOLYSIS; HYDROPHOBICITY; HYPERBILIRUBINEMIA; ITALY; JAUNDICE; NONHUMAN; PHOTOTHERAPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SOLUBILIZATION;

EID: 0029858797     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008903413     Document Type: Article

References (273)

1. Bonnett R, Davies JE, Hursthouse MB, Sheldrick GM. The structure of bilirubin. Proc R Soc Lond B 1978;202:249-268.
2. LeBas G, Allegret A, Mauguen Y, Sheldrick GM, de Rango C, Bailly M. The structure of triclinic bilirubin chloroform-methanol solvate. Acta Crystallogr B 1980;36:3007-3111.
3. 3. Acta Crystallogr C 1983;39:1287-1291.
4. Person RV, Peterson BR, Lightner DA. Bilirubin conformational analysis and circular dichroism. J Am Chem Soc 1994;116:42-59.
5. Navon G, Frank S, Kaplan D. A nuclear magnetic resonance study of the conformation and the interconversion between enantiomeric conformers of bilirubin and mesobilirubin in solution. J Chem Soc Perkin Trans II 1984;11:1145-1149.
6. Brodersen R. Aqueous solubility, albumin binding and tissue distribution of bilirubin. In: Ostrow JD, ed. Bile pigments and jaundice: molecular, metabolic and medical aspects. New York: Dekker, 1986:157-181.
7. Berk PD, Noyer C. Bilirubin metabolism and the hereditary hyperbilirubinemias. Semin Liver Dis 1994;14:321-394.
8. McDonagh AF, Lightner DA. 'Like a shrivelled blood orange' - bilirubin, jaundice and phototherapy. Pediatrics 1985;75:443-455.
9. Lightner DA. Structure, photochemistry and organic chemistry of bilirubin. In: Heirwegh KPM, Brown SB, eds. Bilirubin. Vol. 1. Boca Raton, FL: CRC, 1982:1-58.
10. McDonagh AF, Lightner DA. Phototherapy and photobiology of bilirubin. Semin Liver Dis 1988;8:272-281.
11. McDonagh AF, Lightner DA. The importance of molecular structure in bilirubin metabolism and excretion. In: Bock KW, Gerok W, Matern S, Schmid R, eds. Hepatic metabolism and disposition of endo- and xenobiotics. Dordrecht: Kluwer, 1991:47-59.
12. 13COOH-labelled bilirubin. J Label Compounds and Radiopharm 1994;34:453-462.
13. Nogales D, Lightner DA. On the structure of bilirubin in solution. J Biol Chem 1995;270:73-77.
14. 13C NMR spectroscopy. J Biol Chem 1996;271:2397-2405.
15. 13C-NMR. Tetrahedron 1995;51:1607-1622.
16. Ostrow JD, Mukerjee P, Tiribelli C. Structure and binding of unconjugated bilirubin: relevance for physiological and pathophysiological function. J Lipid Res 1994;35:1715-1737.
17. Lee JJ, Daly LH, Cowger ML. Bilirubin ionic equilibria: their effects on spectra and on conformation. Res Commun Chem Pathol Pharmacol 1974;9:763-770.
18. 13C NMR studies. Acta Chem Scand 1979;33:281-293.
19. Overbeek JTG, Vink CLJ, Deenstra H. The solubility of bilirubin. Rec Trav Chim Pays Bas 1955;74:81-84.
20. Kolosov IV, Shapolovenko EP. Acid-base equilibriums in bilirubin solutions. Zh Obshch Khim 1977;47:2149-2151.
21. Lucassen J. The diazo reaction of bilirubin and bilirubin diglucuronide. Utrecht, the Netherlands: University of Utrecht; Kemink en Zoon, 1961. Thesis.
22. Gray CH, Kulczyka A, Nicholson DC. The chemistry of the bile pigments. IV. Spectrophotometric titration of the bile pigments. J Chem Soc 1961; 2276-2285.
23. Krasner J, Yaffe SJ. The automatic titration of bilirubin. Biochem Med 1973;7:128-134.
24. Moroi Y, Matuura R, Hisadome T. Bilirubin in aqueous solution. Absorption spectrum, aqueous solubility, and dissociation constants. Bull Chem Soc Jpn 1985;58:1426-1431.
25. Hahm JS, Ostrow JD, Mukerjee P, Celic L. Ionization and self-association of unconjugated bilirubin, determined by rapid solvent partition from chloroform, with further studies of bilirubin solubility. J Lipid Res 1992; 33:1123-1137
26. ++ vary from 3 to 12% in non-stoichiometric calcium bilirubinates? [Abstract]. Gastroenterology 1994;106:A359.
27. Yang BJ, Taylor RC, Morris MD, Wang XZ, Wu JG, Yu BZ, Xu GX, et al. Normal coordinate analysis of bilirubin vibrational spectra: effects of intramolecular hydrogen bonding. Spectrochim Acta 1993;49A:1735-1745.
28. Soloway RD, Wu JG, Xu DF. Pigment gallstones and secondary calcification of gallstones. In: Swobodnik W, Soloway RD, Dietschuneit F, eds. Pathophysiology of gallstone development: importance for clinical decision processes. Munich: Springer-Verlag, 1990:35-46.
29. Yang ZL, Soloway RD, Weng SF, Xu DF, Wu JG. Calcium binds with both the carboxyl and pyrrole groups of bilirubinate in in vitro formation of non-stoichiometric salts [Abstract]. Gastroenterology 1991;100:A813.
30. Li WH, Shen GR, Soloway RD, Yang ZL, Tong XB, Wu E, Xu DF, et al. Copper bilirubinate and black pigment gallstone. Biospectroscopy 1995; 1:149-156.
31. Li WH, Shen GR, Soloway RD, Xu ZH, Yang ZL, Guo H, Wu JG. Characterization of black calcium bilirubinate by Fourier transform infrared spectroscopy [Abstract]. Gastroenterology 1991;100:A766.
32. Ohkubo H, Ostrow JD, Carr SH, Rege RV. Polymer networks in pigment and cholesterol gallstones assessed by equilibrium swelling and infrared spectroscopy. Gastroenterology 1984;87:805-814.
33. Mukerjee P. Micellar properties of drugs: micellar and nonmicellar patterns of self-association of hydrophobic solutes of different molecular structures-monomer fraction, availability, and misuses of micellar hypothesis. J Pharm Sci 1974;63:974-981.
34. Mukerjee P, Cardinal JR. Solubilization as a method for studying self-association: solubility of naphthalene in the bile salt sodium cholate and the complex pattern of its aggregation. J Pharm Sci 1976;65:882-886.
35. Mukerjee P, Moroi Y, Murata M, Yang AYS. Bile salts as atypical surfactants and solubilizers. HEPATOLOGY 1984;4:61S-65S.
36. Mukerjee P. Solubilization in aqueous micellar systems. In: Mittal KL, ed. Solution chemistry of surfactants. Vol. I. New York: Plenum, 1979: 153-174.
37. Mukerjee P, Ko JS. Solubilization of o-, m-, and p-ethylaminobenzoates in micelles of different charge types: interfacial adsorption and orientation effects. J Phys Chem 1992;96:6090-6094.
38. 3 into bile salt solutions: Evidence that affinity of B for bile salts increases with ionization of B [Abstract]. Gastroenterology 1993;104:A968.
39. 3 [Abstract]. Gastroenterology 1994;104:A968.
40. 1H-NMR study of bilirubin IXα Solubilization in cholate micelles: application of nuclear Overhauser effects. Biochim Biophys Acta 1987;922:67-77.
41. Conte G, Di Blasi R, Giglio E, Parretta A, Pavel NV. Nuclear magnetic resonance and X-ray studies on micellar aggregates of sodium deoxycholate. J Phys Chem 1984;88:5720-5724.
42. 2O. Acta Crystallogr 1984;C40:631-635.
43. Esposito G, Giglio E, Pavel NV, Zanobi A. Size and shape of sodium deoxycholate micellar aggregates. J Phys Chem 1987;91:356-362.
44. Giglio E, Loreti S, Pavel NV. EXAFS: a new approach to the structure of micellar aggregates. J Phys Chem 1988;92:2258-2262.
45. D'Alagni M, D'Archivio AA, Giglio E, Scaramuzza L. Structure of sodium and rubidium taurodeoxycholate micellar aggregates and their interaction complexes with bilirubin-IXα. J Phys Chem 1994;98:343-353.
46. Campanelli AR, Candeloro de Sanctis S, Chiessi E, D'Alagni M, Giglio E, Scaramuzza L. Sodium glyco- and tauro-deoxycholate: possible helical models for conjugated bile salt micelles. J Phys Chem 1989;93:1536-1542.
47. D'Alagni M, Galantini L, Giglio E, Gavuzzo E, Scaramuzza L. Micellar aggregates of sodium glycocholate and sodium taurocholate and their interaction complexes with bilirubin-IXα. J Chem Soc Faraday Trans 1994;90:1523-1532.
48. Perrin JH, Wilsey M. Induced optical activity of bilirubin in the presence of sodium deoxycholate. J Chem Soc Chem Commun 1971;14:769-770.
49. Reisinger M, Lightner DA. Bilirubin conformational enantiomer selection in sodium deoxycholate chiral micelles. J Incl Phenom 1985;3:479-485.
50. D'Alagni M, Delfini M, Galantini L, Giglio E. A study of the interaction of bilirubin with sodium deoxycholate in aqueous solutions. J Phys Chem 1992;96:10520-10528.
51. Weisiger RA. The role of albumin binding in hepatic organic anion transport. In: Tavoloni N, Berk PD, eds. Hepatic transport and bile secretion: physiology and pathphysiology. New York: Raven, 1993:171-196.
52. Brodersen R. Binding of bilirubin to albumin; implications for prevention of bilirubin encephalopathy in the newborn. CRC Crit Rev Clin Lab Sci 1979;11:305-399.
53. Jacobsen J, Fedders O. Determination of non-albumin-bound bilirubin in human serum. Scand J Clin Lab Invest 1970;26:237-241.
54. Tokumo H, Aoyama N, Busch N, Mancuso DJ, Holzbach RT. Hepatic extraction of organic anions in the rat depends on ligand hydrophobicity. HEPATOLOGY 1991;13:62-67.
55. 3H-unconjugated bilirubin and its uptake by rat liver basolateral plasma membrane vesicles [in press]. Biochem J 1996;313:999-1004.
56. - concentrations [Abstract]. J Hepatol 1995;23 (suppl 1):162.
57. Sorrentino D, Zifrino A, van Ness K, Berk PD. Unbound ligand drives hepatocyte taurocholate and BSP uptake at physiological albumin concentration. Am J Physiol 1994;266:G425-G432.
58. - on organic anion transport in short-term cultured rat hepatocytes and isolated perfused rat liver. J Clin Invest 1987;79: 1259-1265.
59. Blauer G, Harmatz D. Optical properties of bilirubin-serum albumin complexes in aqueous solution. II. Effects of electrolytes and concentration. Biochim Biophys Acta 1972;278:89-100.
60. Luxon BA, Weisiger RA. Extending the multiple indicator dilution method to include slow intracellular diffusion. Math Biosci 1993;113:211-230.
61. D'Alagni M, D'Archivio AA, Giglio E. On the interaction of polypeptides with bile salts or bilirubin IXα. Biopolymers 1993;33:1553-1565.
62. He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature 1992;358:209-215.
63. Brodersen R. Physical chemistry of bilirubin: binding to macromolecules and membranes. In: Heirwegh KPM, Brown SB, eds. Bilirubin. Vol. 1. Boca Raton, FL: CRC, 1982:75-123.
64. Del Vecchio S, Ostrow JD, Mukerjee P, Ton-Nu HT, Schteingart CD, Hofmann AF, Cerré C, et al. Method for removal of surface-active impurities and calcium from conjugated bile salt preparations: comparison with silicic acid chromatography. J Lipid Res 1995;36:2639-2650.
65. Rosen MJ. Purification of surfactants for their fundamental surface properties. J Coll Interf Sci 1981;79:578-588.
66. Kratohvil J, Hsu WP, Jacobs MA, Aminabhavi TM, Mukunoku Y. Concentration-dependent aggregation patterns of conjugated bile salts in aqueous sodium chloride solutions: a comparison between sodium taurodeoxycholate and sodium taurocholate. Colloid Polymer Sci 1983;261:781-785.
67. Mysels KJ. Surface tension of solutions of pure sodium dodecyl sulfate. Langmuir 1986;2:423-428.
68. Rege RV, Webster CC, Ostrow JD. Interactions of unconjugated bilirubin with bile salts. J Lipid Res 1988;29:1289-1296.
69. 3:buffer partition: application to confirm aqueous partition of UCB at pH 6.0-9.0 [Abstract]. Gastroenterology 1992;102: A799.
70. McDonagh AF, Assisi F. The ready isomerization of bilirubin-IXα in aqueous solution. Biochem J 1972;129:797-800.
71. Blanckaert N, Heirwegh KPM. Analysis and preparation of bilirubins and biliverdins. In: Ostrow JD, ed. Bile pigments and jaundice: molecular, metabolic and medical aspects. New York: Dekker, 1986:31-79.
72. Evans EA. Tritium and its compounds. New York: Wiley, 1974:741-745.
73. Lightner DA, Wijekoon WMD, Zhang MH. Understanding bilirubin conformation and binding. Circular dichroism of human serum albumin with bilirubin and its esters. J Biol Chem 1988;263:16669-16676.
74. Spivak W, Carey MC. Reverse-phase h.p.l.c. separation, quantification, and preparation of bilirubin and its conjugates from native bile. Quantitative analysis of the intact tetrapyrroles based on h.p.l.c. of their ethyl anthranilate azo derivatives. Biochem J 1985;225:787-805.
75. Lester R, Schmid R. Bile pigment excretion in Amphibia. Nature 1961; 190:452.
76. Cole KD, Little GH. Bile pigments and bilirubin UDP-glucuronyl transferase during the metamorphosis of Rana calesbeiana tadpoles. Comp Biochem Physiol 1983;766:503-506.
77. Cole KD, Little GH. UDP-glucuronosyltransferase activity and bilirubin conjugation in the bullfrog. Biochem J 1983;212:265-269.
78. Ma JS, Yan F, Wang CQ, Chen JH. Addition of sodium bisulfite to biliverdin. Chin Chem Lett 1990;1:171-173.
79. Colleran E, O'Carra P. Enzymology and comparative physiology of biliverdin reduction. In: Berk PD, Berlin NI, eds. Chemistry and physiology of bile pigments. Washington, DC: DHEW #NIH 77-1100, 1977:69-80.
80. Tiribelli C, Lunazzi GC, Sottocasa GL. Biochemical and molecular aspects of the hepatic uptake of organic anions. Biochim Biophys Acta 1990; 1031:261-275.
81. Tiribelli C. Determinants in the hepatic uptake of organic anions. J Hepatol 1992;14:385-390.
82. Trigatti BL, Mangaroo D, Gerber GE. Photoaffinity labeling and fatty acid permeation in 3T3-L1 adipocytes. J Biol Chem 1991;266:22621-22625.
83. Kramer W, Bickel U, Buscher HP, Gerok W, Kurz G. Bile salt-binding polypeptides in plasma membranes of hepatocytes revealed by photoaffinity labeling. Eur J Biochem 1982;129:13-24.
84. Schramm U, Dietrich A, Schneider S, Buscher HP, Gerok W, Kurz G. Fluorescent derivatives of bile salts. II. Suitability of NBD-amino derivatives of bile salts for the study of biological transport. J Lipid Res 1991; 32:1769-1779.
85. Wolkoff AW, Bhargava MM, Chung CT, Gatmaitan Z. Purification of ligandin by affinity chromatography on sulfobromophthalein-agarose gel. Proc Soc Exp Biol Med 1979;160:150-153.
86. Reichen J, Berk PD. Isolation of an organic anion binding protein from rat liver plasma membrane fractions by affinity chromatography. Biochem Biophys Res Commun 1979;91:484-489.
87. Stremmel W, Gerber MA, Glezerov V, Thung S, Kockwa S, Berk PD. Physicochemical and immunohistological studies of sulfobromophthalein-and bilirubin-binding protein from rat liver plasma membrane. J Clin Invest 1983;71:1796-1805.
88. Wolkoff AW, Chung CT. Identification, purification and partial characterization of an organic anion binding protein from rat liver cell plasma membrane. J Clin Invest 1980;65:1152-1161.
89. Wolkoff AW, Soziak A, Greenblatt HC, van Renswoude J, Stockert RJ. Immunological studies of an organic anion binding protein isolated from rat liver plasma membrane. J Clin Invest 1985;76:454-459.
90. Tiribelli C, Lunazzi G, Luciani GL, Panfili E, Gazzin B, Liut G, Sandri G, et al. Isolation of a sulfobromophthalein-binding protein from hepatocyte plasma membrane. Biochim Biophys Acta 1978;532:105-112.
91. Berk PD, Worman HJ. An introduction to molecular biology and recombinant DNA technology for the hepatologist. Semin Liver Dis 1992;12:227-245.
92. Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 1994;79:427-436.
93. Zhou SL, Stump DD, Kiang CL, Isola LM, Berk PD. Mitochondrial aspartate aminotransferase expressed on the surface of 3T3-L1 adipocytes mediates saturable fatty acid uptake. Proc Soc Exp Biol Med 1995;208: 263-270.
94. Isola LM, Zhou SL, Kiang CL, Stump DD, Bradbury MW, Berk PD. 3T3 fibroblasts transfected with a cDNA for mitochondrial aspartate aminotransferase express plasma mambrane fatty acid-binding protein and saturable fatty acid uptake. Proc Natl Acad Sci U S A 1995;92:9866-9870.
95. Stump DD, Weisiger RA, Berk PD. Transport proteins and molecular biology-is cloning the beginning or the end? HEPATOLOGY 1995;22:669-671.
96. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemter L, Mol CAAM, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993;75:451-462.
97. Heirwegh KPM, de Smedt H, Vermeir M. Unsuspected ligand aggregation: a key problem in biochemical and biological assays with natural and xenobiotic amphipaths. Biochem Educ 1992;20:36-40.
98. Heirwegh KPM, Vermeir M. The error in the Michaelis-Menten equation when substrate depletion by binding to the enzyme is not taken into account [Letter]. Biochem J 1992;283:623-624.
99. Weisiger RA, Pond SM, Bass L. Hepatic uptake of protein-bound ligands: extended sinusoidal perfusion model. Am J Physiol 1991;261:G872-G884.
100. Miccio M, Baldini G, Basso V, Gazzin B, Lunazzi GC, Tiribelli C, Sottocasa GL. Bilitranslocase is the protein responsible for the electrogenic movement of sulfobromophthalein in liver plasma membrane vesicles from rat liver: immunochemical evidence using mono- and poly-clonal antibodies. Biochim Biophys Acta 1989;981:115-120.
101. Potter BJ, Blades BF, Shepard MD, Thung SM, Berk PD. The kinetics of sulfobromophthalein uptake by rat liver sinusoidal vesicles. Biochim Biophys Acta 1987;898:159-171.
102. Torres AM, Lunazzi GC, Stremmel W, Tiribelli C. Bilitranslocase and sulfobromophthalein/bilirubin-binding protein are both involved in the hepatic uptake of organic anions. Proc Natl Acad Sci USA 1993;90: 8136-8139.
103. Stremmel W, Berk PD. Hepatocellular uptake of sulfobromophthalein and bilirubin is selectively inhibited by an antibody to the liver plasma membrane sulfobromophthalein/bilirubin binding protein. J Clin Invest 1986;78:822-826.
104. Sottocasa GL, Baldini G, Sandri G, Lunazzi G, Tiribelli C. Reconstitution in vitro of sulfobromophthalein transport by bilitranslocase. Biochim Biophys Acta 1982;685:1213-128.
105. Geser T, Nakata R, Braly LF, Sosiak A, Campbell CG, Dermietzel R, Novikoff PM, et al. The rat hepatocye plasma membrane organic anion binding protein is immunologically related to the mitochondrial F1 adenosine triphosphatase beta-subunit. J Clin Invest 1990;86:220-227.
106. Jacqemin E, Hagenbuch B, Stieger B, Wolkoff AW, Meier PJ. Expression of the hepatocellular chloride-dependent sulfobromophthalein uptake system in Xenopus laevis oocytes. J Clin Invest 1991;88:2146-2149.
107. +-independent organic anion transporter. Proc Natl Acad Sci U S A 1994;91:133-137.
108. Kullak-Ublick GA, Hagenbuch B, Stieger B, Wolkoff AW, Meier PJ. Functional characterization of the recently cloned basolateral rat liver organic anion transporting polypeptide (oatp). HEPATOLOGY 1994;20:411-416.
109. +-independent multispecific anion transporter mediated active transport of pravastatin into rat liver. Am J Physiol 1993;264:G36-G44.
110. Kanai N, Lu R, Satriano JA, Bao Y, Wolkoff AW, Schuster VL. Identification and characterization of a prostaglandin transporter. Science 1995; 268:866-869.
111. Stieger B, Hagenbuch B, Landmann L, Hoechli M, Schroeder A, Meier PJ. In situ localization of the hepatocytic Na+/tautocholate cotransporting polypeptide (Ntcp) in rat liver. Gastroenterology 1994;107:1781-1787.
112. +/bile acid cotransport system. Proc Natl Acad Sci U S A 1991;88:10629-10633.
113. +/bile acid cotransporter. J Clin Invest 1994;93:1326-1331.
114. Petzinger E, Müller N, Föllmann W, Deutscher J, Kinne RKH. Uptake of bumetanide into isolated rat hepatocytes and primary liver cell cultures. Am J Physiol 1989;256:G78-G86.
115. Moseley RH, Johnson TR, Morrissette JM. Inhibition of bile acid transport by cyclosporine A in rat liver plasma mambrane vesicles. J Pharmacol Exp Ther 1990;253:974-980.
116. Oude Elferink RPJ, Meijer DKF, Kuipers F, Jansen PLM, Groen AK, Groothuis GMM. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim Biophys Acta 1995; 1421:215-268.
117. Arias IM, Che MX, Gatmaitan C, Leveille T, Nishida T, St. Pierre M. The biology of the bile canaliculus. HEPATOLOGY 1993;17:318-329.
118. Kamimoto Y, Gatmaitan Z, Hsu J, Arias IM. The function of gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J Biol Chem 1989;264:11693-11698.
119. Oude Elferink RPJ, Ottenhoff R, van Wijland MJA, Smit JJM, Schinkel AH, Groen AK. Regulation of biliary lipid secretion by mdr-2 P-glycoprotein in the mouse. J Clin Invest 1995;95:31-38.
120. Ruetz S, Gros P. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 1994;77:1071-1082.
121. Smith AJ, Timmermans-Hereijgers JLPM, Roelofsen B, Wirtz KWA, van Blitterswijk WJ, Smit JJM, Schinkel AH, et al. The human MDR3 p-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett 1994; 354:263-266.
122. - rats. In: Tavoloni N, Berk PD, eds. Hepatic transport and bile secretion: physiology and pathophysiology. New York: Raven, 1993: 721-731.
123. Oude Elferink RPJ, Jansen PLM. The role of the multispecific organic anion transporter in the disposition of endo- and xenobiotics. Pharmacol Ther 1994;64:77-97.
124. de Vries MH, Redegeld FA, Koster AS, Noordhoek J, de Haan JG, Oude Elferink RPJ, Jansen PLM. Hepatic, intestinal and renal transport of 1-naphthol-beta-D-glucuronide in mutant rats with hereditary conjugated hyperbilirubinemia. Naunyn Schmiedebergs Arch Pharmacol 1989;340: 588-592.
125. Heijn M, Oude Elferink RPJ, Jansen PLM. ATP-dependent multispecific organic anion transport system in rat erythrocyte membrane vesicles. Am J Physiol 1992;262:C104-C110.
126. Board P, Nishida T, Gatmaitan Z, Che MX, Arias IM. Erythrocyte membrane transport of glutathione conjugates and oxidized glutathione in the Dubin-Johnson syndrome and in rats with hereditary hyperbilirubinemia. HEPATOLOGY 1992;15:722-725.
127. Kuipers F, Enserink M, Havinga R, van der Steen ABM, Hardonk MJ, Fevery J, Vonk RJ. Separate transport systems for biliary secretion of sulfated and unsulfated bile acids in the rat. J Clin Invest 1988;81:1593-1599.
128. Takikawa H, Sano N, Narita T, Uchida Y, Yamanaka M, Horie T, Mikami T, et al. Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat. HEPATOLOGY 1991;14:352-360.
129. -) rats with conjugated hyperbilirubinemia. Proc Natl Acad Sci U S A 1990;87:3557-3561.
130. -) with inherited conjugated hyperbilirubinemia. J Clin Invest 1992;90:2130-2135.
131. Oude Elferink RPJ, Ottenhoff R, Radominska A, Hofmann AF, Kuipers F, Jansen PLM. Inhibition of glutathione-conjugate secretion from isolated hepatocytes by dipolar bile acids and other organic anions. Biochem J 1991;274:281-286.
132. Roelofsen H, Ottenhoff R, Oude Elferink RPJ, Jansen PLM. Hepatocanalicular organic-anion transport is regulated by protein kinase-C. Biochem J 1991;278:637-641.
133. Kothe MJC, Bakker CTM, de Haan JG, Maas A, Jansen PLM, Oude Elferink RPJ. Canalicular organic anion transport after bile duct ligation and reconstruction in the rat [Abstract]. HEPATOLOGY 1993;18:138A.
134. Roelofsen H, van der Veere CN, Ottenhoff R, Schoemaker B, Jansen PLM, Oude Elferink RPJ. Decreased bilirubin transport in the perfused liver of endotoxemic rats. Gastroenterology 1994;107:1075-1084.
135. Zimmerman HJ, Fang M, Utili R, Seeff LB, Hoofmagle JH. Jaundice due to bacterial infection. Gastroenterology 1979;77:362-374.
136. Pikula S, Hayden JB, Awasthi S, Awasthi YC, Zimniak P. Organic-anion transporting ATPase of rat liver. I. Purification, photoaffinity labeling, and regulation by phosphorylation. J Biol Chem 1994;269:27566-27573.
137. Pikula S, Hayden JB, Awasthi S, Awasthi YC, Zimniak P. Organic anion transporting ATPase of rat liver. II. Functional reconstitution of active transport and regulation by phosphorylation. J Biol Chem 1994;269: 27274-27579.
138. - rat [Abstract]. HEPATOLOGY 1995;22:295A.
139. Jedlitschky G, Leier I, Buchholz U, Center M, Keppler D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 1994;54:4833-4836.
140. Muller M, Meijer C, Zaman GJR, Borst P, Scheper RJ, Mulder NH, de Vries EGE, et al. Overexpression of the gene encoding the multidrug resistance associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci U S A 1994;91:13033-13037
141. Zaman GJR, Versantvoort CHM, Smit JJM, Eijdems EWHM, de Haas M, Smith AJ, Broxterman HJ, et al. Analysis of the expression of MRP, the gene for a new putative transmembrane transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 1993;53:1747-1750.
142. Tiribelli C, Lunazzi GC, Sottocasa GL. Biology of bilitranslocase. In: Tavoloni N, Berk PD, eds. Hepatic transport and bile secretion: physiology and pathophysiology. New York: Raven Press, 1995:235-244.
143. Torres AM, Rodriguez JV, Lunazzi GC, Tiribelli C. Carrier-mediated transport of tetrabromosulfonephthalein by rat liver plasma membrane vesicles. Am J Physiol 1992;263:G338-G344.
144. Luby-Phelps K. Physical properties of cytoplasm. Curr Opin Cell Biol 1994; 6:3-9.
145. Luxon BA, Weisiger RA. A new method for quantitating cytoplasmic transport: application to the thyroid hormone 3,5,3′-triiodothyronine. Am J Physiol 1992;263:G733-G741.
146. Luxon BA, Weisiger RA. Sex differences in intracellular fatty acid transport: role of cytoplasmic binding proteins. Am J Physiol 1993;265:G831-G841.
147. Meuwissen JATP, Ketterer B, Heirwegh KPM. Role of soluble binding proteins in overall hepatic transport of bilirubin. In: Berk PD, Berlin NI, eds. Chemistry and physiology of bile pigments. 1977:323-337.
148. Tipping E, Ketterer B. The influence of soluble binding proteins on lipophile transport and metabolism in hepatocytes. Biochem J 1981;195:441-452.
149. Zucker SD, Storch J, Zeidel ML, Gollan JL. Mechanism of the spontaneous transfer of unconjugated bilirubin between small unilamellar phosphatidylcholine vesicles. Biochemistry 1992;31:3184-3192.
150. Kremer JMH, Esker MWJ, Pathmamanoharan C, Wiersema PH. Vesicles of variable diameter prepared by a modified injection method. Biochemistry 1977;16:3932-3935.
151. Zucker SD, Gössling W, Zeidel ML, Gollan JL. Membrane lipid composition and vesicle size modulate bilirubin intermembrane transfer: evidence for membrane-directed trafficking of bilirubin in the hepatocyte. J Biol Chem 1994;269:19262-19270.
152. Zucker SD, Gössling W, Ransil BJ, Gollan JL. Influence of glutathione S-transferase B (ligandin) on the intermembrane transfer of bilirubin - implications for the intracellular transport of nonsubstrate ligands in hepatocytes. J Clin Invest 1995;98:1927-1935.
153. Crawford JM, Gollan JL. Tr ans cellular transport of organic anions in hepatocytes: still a long way to go [Editorial]. HEPATOLOGY 1991;14:192-197.
154. Tephly TR, Burchell B. UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Physiol Sci 1990;111:276-279.
155. Berg CL, Radominska A, Lester R, Gollan JL. Membrane translocation and regulation of uridine-diphosphate-glucuronic acid uptake in rat liver microsomal vesicles. Gastroenterology 1995;108:183-192.
156. Hauser SC, Ziurys JC, Gollan JL. A membrane transporter mediates access of uridine 5′-diphosphoglucuronic acid from the cytosol into endoplasmic reticulum of rat hepatocytes: implications for glucuronidation reactions. Biochim Biophys Acta 1988;967:149-157.
157. Bossuyt X, Blanckaert N. Mechanism of stimulation of UDP-glucuronosyltransferase by UDP-N-acetylglucosamine. Biochem J 1995;305:321-328.
158. Zakim D, Goldenberg J, Vessey DA. Effects of metals on the properties of hepatic microsomal uridine diphosphate glucuronyl transferase. Biochemistry 1973;12:4068-4074.
159. Berg CL, Pelletier EM, Gollan JL. Regulation of hepatic microsomal UDP-glucuronic acid transport by divalent cations [Abstract]. Gastroenterology 1995;108:A1034.
160. Berg CL, Pelletier EM, Gollan JL. Selective effects of UDP-glucuronosyltransferase substrates on hepatic microsomal uptake of UDP-glucuronic acid [Abstract]. Gastroenterology 1994;106:A866.
161. Bossuyt X, Blanckaert N. Carrier-mediated transport of intact UDP-glucuronic acid into the lumen of endoplasmic-reticulum-derived vesicles from rat liver. Biochem J 1994;302:261-269.
162. Bossuyt X, Blanckaert N. Functional characterization of carrier-mediated transport of uridine diphosphate N-acetylglucosamine across the endoplasmic reticulum membrane. Eur J Biochem 1994;223:981-988.
163. Aono S, Adachi Y, Uyama E, Yamada Y, Keino H, Nanno T, Koiwai O, et al. Analysis of genes for bilirubin UDP-glucuronosyltransferase genes in Gilbert's syndrome. Lancet 1995;345:958-959.
164. Peters WHM, Jansen PLM, Nauta H. The molecular weights of UDP-glucuronyl transferase determined with radiation inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase. J Biol Chem 1984;259:11701-11705.
165. Koiwai O, Nishizawa N, Hasada K, Aono S, Adachi Y, Mamiya N, Sato H. Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase. Hum Mol Genet 1995;4:1183-1186.
166. Bosma PJ, Roy Chowdhury J, Bakker CTM, Gantla S, de Boer A, Oostra BA, Lindhout D, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995;333:1171-1175.
167. Bratlid D. Criteria for the treatment of neonatal jaundice [in press]. J Perinatol 1996.
168. Odell GB. Neonatal hyperbilirubinemia. New York: Grune & Stratton, 1980:35.
169. Bratlid D. How bilirubin gets into the brain. Clin Perinatol 1990;17:449-465.
170. Maisels MJ. Bilirubin. On understanding and influencing its metabolism in the newborn infant. Pediatr Clin North Am 1972;19:447-501.
171. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term infant: a kinder, gentler approach. Pediatrics 1992;89:809-818.
172. Brodersen R. Prevention of kernicterus, based on recent progress in bilirubin chemistry. Acta Paediatr Scand 1977;66:625-634.
173. Funato M, Tamai H, Shimada S, Nakamura H. Vigintiphobia, unbound bilirubin and brainstem responses. Pediatrics 1994;93:50-53.
174. Perlman M, Fainmesser P, Sohmer H, Tamari H, Wax Y, Pevsmer B. Auditory nerve-brainstem evoked responses in hyperbilirubinemic neonates. Pediatrics 1983;72:658-664.
175. Rye HH. Psychological investigations of premature infants. A longitudinal study from 3 years until elementary school [Thesis, University of Oslo]. Oslo: Sentralinstituttet for Cerebral Parese, 1981.
176. Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R. Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics 1991;88:828-833.
177. Connolly AM, Volpe JJ. Clinical features of bilirubin encephalopathy. Clin Perinatol 1990;17:371-379.
178. van de Bor M, van Zeben-van der Aa TM, Verloove-Vanhorick SP, Brand R,
179. Seidman DS, Stevenson DK, Ergaz Z, Gale R. Hospital readmission due to neonatal hyperbilirubinemia. Pediatrics 1995;96:727-729.
180. Wennberg RP. The importance of free bilirubin acid salt in bilirubin uptake by erythrocytes and mitochondria. Pediatr Res 1988;23:443-447.
181. Nakamura H, Yonetani M, Uetani Y, Funato M, Lee Y. Determination of unbound serum bilirubin for prediction of kernicterus in low birthweight infants. Acta Paediatr Jpn 1992;34:642-647.
182. Cashore WJ. Bilirubin binding tests. In: Levine RL, Maisels MJ, eds. Hyperbilirubinemia in the newborn. Columbus, OH: Report of 85th Ross Conference on Pediatric Research, 1983:101-110.
183. Shimabuku R, Nakamura H. Total and unbound bilirubin determination using an automated peroxidase micromethod. Kobe J Med Sci 1982;28: 91-104.
184. Hofmann AF. Extraction of polar anionic lipids with tetraheptylammonium chloride, a liquid anion exchanger. J Lipid Res 1967;8:55-58.
185. Stevenson DK, Vreman HJ. Evaluation of neonatal jaundice: monitoring the transition in bilirubin metabolism [in press]. J Perinatol 1996.
186. Bartoletti AL, Stevenson DK, Ostrander CR, Johnson JD. Pulmonary excretion of carbon monoxide in human newborn infants is an index of bilirubin production. I. Effects of gestational and postnatal age and some common neonatal abnormalities. J Pediatr 1979;94:952-955.
187. Dennery PA, Rhine WD, Stevenson DK. Neonatal jaundice. What now? Clin Pediatr 1995;34:103-107.
188. Penn AA, Enzmann DR, Hahn JS, Stevenson DK. Kernicterus in a full-term infant. Pediatrics 1994;93:1003-1006.
189. Yao TC, Stevenson DK. Advances in the diagnosis and treatment of neonatal hyperbilirubinemia. Clin Perinatol 1995;22:741-758.
190. Schreiner RL, Glick MR. Interlaboratory bilirubin variability. Pediatrics 1982;69:277-281.
191. Vreman HJ, Stevenson DK, Oh W, Lemons JA, Verter J, Fanaroff AA, Wright LL. Variability of interlaboratory bilirubin measurements [Abstract]. Pediatr Res 1995;37:243A.
192. Tenhunen R, Marver HS, Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 1969;244:6388-6394.
193. Vreman HJ, Stevenson DK, Henton D, Rosenthal P. Correlation of carbon monoxide and bilirubin production by tissue homogenates. J Chromatogr Biomed Appl 1988;427:315-319.
194. Hintz SR, Kwong LK, Vreman HJ, Stevenson DK. Recovery of exogenous heme as carbon monoxide and biliary heme in adult rats after tin protoporphyrin treatment. J Pediatr Gastroenterol Nutr 1987;6:302-306.
195. Ostrander CR, Cohen RS, Hopper AO, Cowan BE, Stevens GB, Stevenson DK. Paired determinations of blood carboxyhemoglobin concentration and carbon monoxide excretion rate in term and preterm infants. J Lab Clin Med 1982;100:745-755.
196. Vreman HJ, Stevenson DK. Determination of carboxyhemoglobin in neonatal blood with a CO-oximeter unaffected by fetal oxyhemoglobin. Clin Chem 1994;40:1522-1527.
197. Stevenson DK, Vreman HJ, Oh W, Fanaroff AA, Wright LL, Lemons JA, Verter J, et al. Bilirubin production in healthy term infants as measured by carbon monoxide in breath. Clin Chem 1994;40:1934-1939.
198. Vreman HJ, Stevenson DK, Oh W, Fanaroff AA, Wright LL, Lemons JA, Wright E, et al. Semiportable electrochemical instrument for determining carbon monoxide in breath. Clin Chem 1994;40:1927-1933.
199. Vreman HJ, Baxter L, Stone RT, Stevenson DK. Evaluation of a fully automated end-tidal carbon monoxide instrument for breath analysis. Clin Chem 1996;42:50-56.
200. Odell GB, Gutcher GR, Whitington PF, Yang G. Enteral administration of agar as an adjunct to phototherapy of neonatal hyperbilirubinemia. Pediatr Res 1983;17:810-814.
201. Ulstrom RA, Eisenklam E. The enterohepatic shunting of bilirubin in the newborn infant. I. Use of oral activated charcoal to reduce normal serum bilirubin values. J Pediatr 1964;65:27-37.
202. Ostrow JD. Therapeutic amelioration of jaundice. HEPATOLOGY 1988;8: 683-689.
203. van der Veere CN, Schumaker B, van der Meer R, Groen AK, Jansen PLM, Oude Elferink RPJ. Dietary calcium phosphate lowers serum bilirubin levels in Gunn rats [Abstract]. HEPATOLOGY 1993;18:127A.
204. Lavin A, Sung C, Klibanov AM, Langer R. Enzymatic removal of bilirubin from blood: a potential treatment of neonatal jaundice. Science 1985;230: 543-545.
205. Drummond GS, Valaes T, Kappas A. Control of bilirubin production by synthetic heme analogues: pharmacological and toxicological considerations [in press]. J Perinatol 1996.
206. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Soc Exp Biol Med 1968; 61:748-755.
207. Valaes T, Petmezaki S, Henschke CI, Drummond GS, Kappas A. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin mesoporphyrin. Pediatrics 1994;93:1-11.
208. Kappas A, Simionatto CS, Drummond GS, Sassa S, Anderson KE. The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin. Proc Natl Acad Sci U S A 1985;82:896-900.
209. Drummond GS, Kappas A. Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc Natl Acad Sci U S A 1981;78:6466-6470.
210. Drummond GS, Galbraith RA, Sardana MK, Kappas A. Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolism. Arch Biochem Biophys 1987;255:64-74.
211. Cannon JB, Martin C, Drummond GS, Kappas A. Targeted delivery of a heme oxygenase inhibitor with a lyophilized liposomal tin mesoporphyrin formulation. Pharm Res 1993;10:715-721.
212. Drummond GS, Rosenberg DW, Kihlstrom-Johanson AC, Kappas A. Effects of tin-porphyrins on developmental changes in hepatic cytochrome P450 content; selected P450-dependent drug-metabolizing enzyme activities and brain glutathione levels in the newborn rat. Pharmacology 1989; 39:273-284.
213. Galbraith RA, Kappas A. Pharmacokinetics of tin-mesoporphyrinin in man and the effects of tin-chelated porphyrins on hyperexcretion of heme pathway precursors in patients with acute inducible porphyria. HEPATOLOGY 1989;9:882-888.
214. Galbraith RA, Drummond GS, Kappas A. Suppression of bilirubin production in the Crigler-Najjar type I syndrome: studies with the heme oxygenase inhibitor, Sn-mesoporphyrin. Pediatrics 1992;89:175-182.
215. Dennery PA, Wong HE, Rodgers PA, Stevenson DK, Shokoohi V. Increased HO-1 expression in cultures of rat fetal lung cells after metalloporphyrin administration [Abstract]. Pediatr Res 1995;37:202A.
216. Sardana MK, Kappas A. Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver. Proc Natl Acad Sci U S A 1987;84:2462-2468.
217. Lutton JD, Chertkov JL, Levere RD, Abraham NG. Comparative effects of heme analogues on hematopoiesis in lymphoproliferative disorders. Leuk Lymphoma 1991;5:179-185.
218. Kappas A, Drummond GS, Henschke CI, Valaes T. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns. Pediatrics 1995;95:468-474.
219. Dennery PA, Rodgers PA. Ontogeny and developmental regulation of heme oxygenase [in press]. J Perinatol 1996.
220. Tom DJ, Rodgers PA, Stevenson DK, Dennery PA. Heme oxygenase induction in neonatal rats after cobalt chloride administration [in press]. Pediatr Res 1996.
221. Lin JH, Villalon P, Nelson JC, Abraham NG. Expression of rat liver heme oxygenase gene during development. Arch Biochem Biophys 1989;270: 623-629.
222. Rodgers PA, Lee CS, Stevenson DK, Dennery PA. Ontogeny of lung heme oxygenase in the neonatal Wistar rat [Abstract]. Pediatr Res 1995;37: 234A.
223. Vile GF, Basu-Modak S, Waltner C, Tyrrell RM. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc Natl Acad Sci U S A 1994;91:2607-2610.
224. Dennery PA, Spitz DR, Wong HE. Antisense transfection with heme oxygenase (HO-1) abolishes resistance to hyperoxia without decreases in ferritin protein levels in hamster fibroblasts [Abstract]. Pediatr Res 1995; 37:202A.
225. Allen RG, Venkatraj VS. Oxidants and antioxidants in development and differentiation. J Nutr 1992;122:631-635.
226. Kim BH, Takahashi M, Tada K, Bosma PJ, Roy Chowdhury J, Roy Chowdhury N. Cell and gene therapy for inherited deficiency of bilirubin glucuronidation [in press]. J Perinatol 1996.
227. Makowka L, Rotstein LE, Falk RE, Falk JA, Langer B, Nossal NA, Blendis LM, et al. Reversal of toxic and anoxic induced hepatic failure by syngeneic, allogeneic and xenogeneic hepatocyte transplantation. Surgery 1980;88:244-253.
228. Vroemen JP, Blanckaert N, Buurman WA, Heirwegh KPM, Koostra G. Treatment of enzyme deficiency by hepatocyte transplantation in rats. J Surg Res 1985;39:267-275.
229. Reid LM, Rojkind M. New techniques for culturing differentiated cells: reconstituted basement membrane. Methods Enzymol 1979;58:263-278.
230. Demetriou AA, Whiting JF, Feldman D, Levenson SM, Roy Chowdhury N, Moscioni AD, Kram M, et al. Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science 1986;233: 1190-1192.
231. Demetriou AA, Levenson SM, Novikoff PM, Novikoff AB, Roy Chowdhury N, Whiting JF, Reisner A, et al. Survival, organization and function of microcarrier-attached hepatocytes transplanted in rats. Proc Natl Acad Sci U S A 1986;83:7475-7479.
232. Rozga J, Bellew T, Demetriou AA. Transplantation of microencapsulated hepatocytes into analbuminemic rats. Surg Forum 1991;42:419-421.
233. Mito M, Ebata H, Kusano M, Onishi T, Saitoh T, Sakamoto S. Morphology and function of isolated hepatocytes transplanted into rat spleen. Transplantation 1979;28:499-506.
234. Demetriou AA, Holzman MD, Moscioni AD. Hepatic cell transplantation. Adv Vet Sci Compar Med 1993;37:313-332.
235. Moscioni AD, Rozga J, Morsiani E, Scott H, Demetriou AA. Long-term survival after intraportal hepatocyte transplantation. Surg Forum 1993; 44:126-127.
236. Fabrega AJ, Bommineni VR, Blanchard J, Tetali S, Rivas P, Pollack R, Sengupta K, et al. The amelioration of analbuminemia by transplantation of allogeneic hepatocytes in tolerized rats. Transplantation 1995;59:1362-1364.
237. Bommineni VR, van Duijvendijk P, Kim BH, Sengupta K, Attavar P, Roy Chowdhury N, Roy Chowdhury J. Tolerization to alloantigens by thymic re-education in Gunn rats; long-term amelioration of jaundice following transplantation of allogeneic hepatocytes [Abstract]. Gastroenterology 1995;108:1038A.
238. Wilson JM, Wu GY, Wu CH, Grossman M, Roy Chowdhury N, Roy Chowdhury J. Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in LDL-receptor-deficient rabbits. J Biol Chem 1992;267:963-967.
239. Roy Chowdhury N, Wu CH, Wu GY, Yerneni PC, Bommineni VR, Roy Chowdhury J. Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo: prolonged persistence in cytoplasmic vesicles after partial heoatectomy. J Biol Chem 1993;268:11265-11271.
240. Bommineni VR, Roy Chowdhury N, Wu GY, Wu CH, Franki N, Hays RM, Roy Chowdhury J. Depolymerization of hepatocellular microtubules after partial hepatectomy. J Biol Chem 1994;269:25200-25205.
241. Tada K, Prasad VR, Bosma PJ, Heard M, Neufield D, Roy Chowdhury N, Roy Chowdhury J. Retrovirus-mediated transfer of human bilirubin-UDP-glucuronosyltransferase-1 gene into the Gunn rat liver in vivo results in amelioration of jaundice: a model for gene therapy for Crigler-Najjar syndrome [Abstract]. J Invest Med 1995;43:329A.
242. Fox IJ, Roy Chowdhury N, Gupta S, Kondapalli R, Schilsky ML, Stockert RJ, Roy Chowdhury J. Conditional immortalization of Gunn rat hepatocytes: an ex vivo model for evaluating methods for bilirubin-UDP-glucuronosyltransferase gene transfer. HEPATOLOGY 1995;21:837-846.
243. Takahashi M, Roy Chowdhury N, Tada K, Bosma PJ, Oude Elferink RPJ, Roy Chowdhury J. Development of a recombinant adenovirus capable of completely correcting the bilirubin glucuronidation defect in Gunn rats: a model for in vivo gene therapy for Crigler-Najjar syndrome [Abstract]. J Invest Med 1995;43:277A.
244. Takahashi M, Sengupta K, Roy Chowdhury N, Roy Chowdhury J. Prolonged expression of bilirubin-UDP-glucuronosyltransferase-1 after adenovirus-mediated gene transfer into newborn Gunn rats [Abstract]. HEPATOLOGY 1995;22:220A.
245. Fausto N, Mead J. Regulation of liver growth: Protooncogenes and transforming growth factors. Lab Invest 1989;60:4-13.
246. Fishback FC. A morphological study of regeneration of the liver after partial removal. Arch Pathol 1929;7:955-977.
247. Jones EA, Schafer DF. Fulminant hepatic failure. In: Zakim D, Boyer TD, eds. A textbook of liver disease. Philadelphia, PA: Saunders, 1990: 460-492.
248. Bernuau J, Benhamou JP. Fulminant and subfulminant liver failure. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, eds. Oxford textbook of clinical hepatology. Oxford, England: Oxford University, 1991:923-942.
249. Karvountzis GG, Redeker AG, Peters RL. Long term follow-up studies of patients surviving fulminant viral hepatitis. Gastroenterology 1974;67: 870-877.
250. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445.
251. Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, Degott C, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. HEPATOLOGY 1986;6:648-651.
252. Starzl TE, Demetris AJ, van Theil DH. Liver transplantation. N Engl J Med 1989;321:1014-1022.
253. Basile AS, Hughes RD, Harrison PM, Murata Y, Pannell L, Jones EA, Williams R, et al. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med 1991;325:473-478.
254. Hughes RD, Cochrane MG, Thompson AD, Murray-Lyon IM, Williams R. The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. Br J Exp Pathol 1976;57:348-353.
255. Ash SR, Blake DE, Carr DJ, Carter C, Howard T, Makowka L. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma. Int J Artif Organs 1992;15:151-161.
256. O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trial of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-1192.
257. Eiseman B, Liem DS, Raffucci F. Heterologous liver perfusion in treatment of hepatic failure. Ann Surg 1965;162:329-345.
258. Sussman NL, Kelly JH. Temporary hepatic support systems - the then and the maybe. In: Maddrey WC, Sorrell MF, eds. Transplantation of the liver. Norwalk, CT: Appleton & Lange, 1995:557-569.
259. Uchino J, Tsuburaya T, Kumagai F, Hase T, Hamada T, Komai T, Funatsu A, et al. A hybrid bioartifical liver composed of multiplated hepatocyte monolayers. ASAIO Trans 1988;34:972-977.
260. Sussman NL, Chong MG, Koussayer T, He D, Shang TA, Whisennand HH, Kelly JH. Reversal of fulminant hepatic failure using an extracorpo real liver assist device. HEPATOLOGY 1992;16:60-65.
261. Rozga J, Williams F, Ro MS, Neuzil DF, Giorgio TD, Backfisch G, Moscioni AD, et al. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. HEPATOLOGY 1993; 17:258-265.
262. Rozga J, Podesta L, LePage E, Hoffman A, Morsiani E, Sher L, Woolf GM, et al. Control of cerebral oedema by total hepatectomy and extracorporeal liver supportin fulminant hepatic failure. Lancet 1993;342:898-899.
263. Rozga J, Podesta L, LePage E, Morsiani E, Moscioni AD, Hoffman A, Sher L, et al. A bioartificial liver to treat severe acute hepatic failure. Ann Surg 1994;219:538-546.
264. Nyberg SL, Payne WD, Amiot B, Shirabe K, Remmel RP, Hu WS, Cerra FB. Demonstration of biochemical function by extracorporeal xenohepatocytes in an anhepatic animal model. Transplant Proc 1993;25:1944-1945.
265. Li AP, Barker G, Beck D, Colburn S, Monsell R, Pellegrin C. Culturing of primary hepatocytes as entrapped aggregates in a packed bed bioreactor: a potential bioartificial liver. In Vitro Cell Dev Biol 1993;29A:249-254.
266. Rozga J, Holzman MD, Griffin DW, Ro MS, Neuzil DF, Moscioni AD, Demetriou AA. Development of a hybrid xenogeneic bioartificial liver. Surg Forum 1992;43:174-176.
267. Kelly JH, Koussayer T, He D, Chong MG, Shang TA, Whisennand HH, Sussman NL. An improved model of acetaminophen induced fulminant hepatic failure in dogs. HEPATOLOGY 1992;15:329-335.
268. Sussman NL, Kelly JH. Extracorporeal liver assist in the treatment of fulminant hepatic failure. Blood Purifie 1993;11:170-174.
269. Sussman NL, Kelly JH. Improved liver function following treatment with an extracorporeal liver assist device. Artif Organs 1993;17:27-30.
270. Sussman NL, Gislason GT, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs 1994;18: 390-396.
271. Ellis AJ, Wendon J, Hughes RD, Langley P, Sussman NL, Kelly JH, Gislason GT. A controlled trial of the Hepatix extracorporeal liver assist device (ELAD) in acute liver failure [Abstract]. HEPATOLOGY 1994;20:140A.
272. Tiribelli C, Ostrow JD. New concepts in bilirubin chemistry, transport, and metabolism: report of the International Bilirubin Workshop, April 6-8, 1989. HEPATOLOGY 1990;11:303-313.
273. Tiribelli C, Ostrow JD. New concepts in bilirubin chemistry, transport and metabolism: report of the International Bilirubin Workshop, April 9-11, 1992, Trieste, Italy. HEPATOLOGY 1993;17:715-736.